Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer and male factor infertility

R A Costabile1, M Spevak

  • 1Department of Surgery, Walter Reed Army Medical Center, Washington, DC, USA.

Oncology (Williston Park, N.Y.)
|May 12, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alprostadil for the treatment of erectile dysfunction.

Expert opinion on investigational drugs·2005
Same author

Use of oral ketoconazole to prevent postoperative erections following penile surgery.

International journal of impotence research·2004
Same author

Characterization of patients presenting with male factor infertility in an equal access, no cost medical system.

Urology·2001
Same author

The prevalence of testicular microlithiasis in an asymptomatic population of men 18 to 35 years old.

The Journal of urology·2001
Same author

Retroperitoneal bronchogenic cyst mimicking a pheochromocytoma.

The Journal of urology·2001
Same author

Changing trends in partial nephrectomy at Walter Reed Army Medical Center.

Military medicine·2001
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Cancer survivors can preserve fertility. Treatments may impact sperm production, but recovery is possible, and assisted reproductive technologies offer options for fatherhood.

Area of Science:

  • Oncology
  • Reproductive Medicine
  • Men's Health

Background:

  • Multimodality anticancer therapies improve survival rates for men of reproductive age.
  • Fertility and sexual function concerns are paramount for cancer survivors.
  • Pretreatment fertility abnormalities are observed in men with germ cell tumors and Hodgkin's disease.

Purpose of the Study:

  • To review the impact of cancer therapy on male reproductive function.
  • To discuss strategies for preserving fertility during cancer treatment.
  • To highlight advancements in assisted reproductive techniques for cancer patients.

Main Methods:

  • Review of current literature on cancer therapy and male fertility.
  • Analysis of treatment modalities affecting spermatogenesis.

Related Experiment Videos

  • Evaluation of fertility preservation and assisted reproductive techniques.

    • Main Results:

    • Cancer therapies can cause temporary or permanent damage to spermatogonia, leading to infertility.
    • Spermatogenesis recovery may take up to 10 years post-therapy.
    • Surgical techniques can preserve neurovascular mechanisms for ejaculation.
    • Assisted reproductive technologies enable fatherhood even in cases of severe oligoasthenospermia without increasing birth defect rates.

    Conclusions:

    • Fertility preservation is a key aspect of survivorship care in oncology.
    • Alternative treatment regimens and surgical approaches can maintain reproductive function.
    • Assisted reproductive technologies provide viable options for cancer patients seeking to father children.